A Study to Evaluate Early Treatment Outcomes With Miebo™ in Subjects With Dry Eye Disease - Trial NCT06309953
Access comprehensive clinical trial information for NCT06309953 through Pure Global AI's free database. This Phase 4 trial is sponsored by Bausch & Lomb Incorporated and is currently Recruiting. The study focuses on Dry Eye. Target enrollment is 100 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Bausch & Lomb Incorporated
Timeline & Enrollment
Phase 4
Feb 28, 2024
Jun 28, 2024
Primary Outcome
Mean change from baseline (CFB) in dry eye symptom severity at Visit 3
Summary
An Open-Label, Multicenter, Phase 4 Study to Evaluate Early Treatment Outcomes With Miebo™ in
 Subjects With Dry Eye Disease
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06309953
Non-Device Trial